CASE STUDIES
AstraZeneca cuts costs, boosts productivity with unified data.
AstraZeneca replaced 67 legacy MDM solutions with 3 Reltio instances, saving £3.6 million in annual infrastructure and management costs—and increasing operational efficiencies.
“We're accelerating innovation to deliver life-changing medicines and personalized experiences—replacing 67 MDM systems with 3 interlinked regional hubs in Europe, APAC, and the US.”
Joanna Walker,
Commercial Excellence Program Manager, IT
Legacy MDMs reduced operating efficiency and productivity.
High costs and redundancy due to 67 deployments.
Extremely difficult and costly to manage and upgrade complex, on-premise legacy software at this scale.
Inefficient sales processes and low productivity.
With 67 systems, sales reps faced poor response time and no single source of truth, slowing processes.
Disjointed communications with no control over marketing data.
Outsourced marketing lacked single view of patient across brands and deployments, challenging UX and compliance.
“Reltio is at the heart of our digital innovation and customer experience initiatives. Reltio empowers 1,000s of sales reps and 100s of data stewards with the most up-to-date, trusted customer profiles.
It allows us to manage customer data in a way that is agile, scalable, and smart.”
Joanna Walker
Commercial Excellence Program Manager, IT
Why AstraZeneca chose our platform.
With 67 MDM instances across 140+ countries, AstraZeneca wanted to simplify its landscape, ensure scalability, increase performance, and reduce costs.
Modern MDM to deliver trusted data across enterprise.
Reltio aligned with AstraZeneca CIO’s vision for simplification, scalability, and data unification.
Seamless integration to downstream systems.
It needed to integrate with Veeva CRM, marketing apps, third-party data providers, and more.
Flexibility and adaptability to business needs.
AstraZeneca wanted to design and adopt a global data model across many local markets and brands.
Low-latency performance with massive data volumes.
Our responsive mobile UI and robust indexing would enable ultra-fast searches.
AstraZeneca's solution.
Simplified architecture with cloud-native, SaaS MDM.
Replaced 67 local MDM systems across the globe with 3 interlinked regional hubs.
Integrated Reltio with its new marketing platform.
Adobe marketing integration centralized patient and consumer data management.
Adopted Reltio for consent and preference management.
Centralized consent in sync across systems for customer marketing preferences.
Deployed mobile version of the Reltio UI.
Our simple, mobile UI enabled more efficient access to data by sales reps.
£3.6M
annual MDM cost savings
10X
productivity boost for sales reps
14 weeks
to live patient master
AstraZeneca gained these benefits
with Reltio.
£3.6 million savings in annual infrastructure costs.
Eliminated operating costs associated with management of 67 on-premise MDM instances.
Increased sales rep and data steward productivity.
Faster, easier searches and new data sets enabled richer customer conversations with less work.
Enhanced customer experience and communications.
Trusted patient/consumer data improved CX and enabled consistent, accurate communications.
Improved consent management and reduced compliance risk.
Centralized management of consent—in sync and accurate—simplified compliance.
Discover more success stories.
Explore how other industry leaders are achieving success with Reltio.
Ready to
see it in action?
See how Reltio Context Intelligence Platform can give you the speed and flexibility you need to accelerate the value of your data and maximize its impact every day.